|
October
2008
All
data as of 28 October 2008 English
(pdf ) French
(pdf )
-
NEJM publishes studies confirming feasibility of polio eradication:
On 16 October, two important studies affirming the technical feasibility of
polio eradication were published in the New England Journal of Medicine. The
studies evaluated the efficacy of monovalent oral polio vaccine type 1
(mOPV1) compared with trivalent OPV in northern Nigeria, as well as among
newborn children in Egypt. Both studies found mOPV1 to be significantly more
effective than trivalent OPV. The programmatic implications of these studies
are significant. The seroconversion results indicate that mOPV1 has the
capacity to rapidly stop this year's type 1 polio outbreak in northern
Nigeria, if the quality of vaccination campaign operations is improved. At
the same time, the results indicate that in key endemic areas such as
northern India the immunity gap against type 1 in the youngest children
(who are most vulnerable to polio) can be bridged more rapidly by mOPV1.More.
-
WHO DG and EMRO RD express concern over recent rise in polio cases in
Pakistan: WHO Director-General Dr Margaret Chan and Regional Director
for WHO's Eastern Mediterranean Office Dr Hussein A Gezairy have expressed
concern over the recent rise in polio cases affecting Pakistan. Addressing
the health ministers from EMRO's 22 countries at the annual Regional
Committee on 11 October in Cairo, Egypt, Dr Chan stated: "In Pakistan, we
are now experiencing an outbreak in previously polio-free regions and
outside the key endemic areas. This resurgence clearly demonstrates that
polio eradication must be completed. Control is not an option." Dr Chan
and Dr Gezairy also paid tribute to three polio staff members killed while
on duty when a suicide bomb hit their convoy on 14 September as they were on
their way to prepare for a polio immunization campaign. (See September
monthly situation report for more.)
India
-
In 2008, 496 cases have
been reported (59 type 1 and 437 type 3).
-
In western Uttar Pradesh,
an aggressive response continues to the type 1 outbreak, with further
campaigns to be held in November and December, following an October round.
In total, six large-scale campaigns will have been conducted with mOPV1 in
this area in the second half of 2008. Free of endemic type 1 polio for
nearly 18 months, the core highest-risk districts of western Uttar Pradesh
have recently experienced local spread of type 1 originally imported from
Bihar.
-
In Bihar, catch-up
campaigns were held in several districts which had not been covered during
the recent activities in September, due to extensive flooding. As in western
Uttar Pradesh, additional campaigns will be held in November and December.
-
With upcoming large-scale
population movements expected in November between Bihar and Uttar Pradesh
during the festival season, special transit vaccination teams are being
deployed to major transit points and gathering sites.
-
Interrupting type 1
transmission in India this year remains a primary strategic objective of the
Global Polio Eradication Initiative. Key to success is sustaining the
political momentum which has brought India so close to eradicating type 1
polio. In 2008, 18 districts are infected with type 1 polio, compared to 40
districts for the same period in 2007 (a 55% reduction in type 1-infected
districts).
Nigeria
-
In 2008, 736 cases have
been reported (677 type 1 and 58 type 3).
-
In Nigeria, state-level
analyses of operations are being conducted, based on performance during the
most recent Immunization Plus Days, in August. The outcomes will drive
operational planning for upcoming activities.
-
Convening in Abuja on
27-28 October, the Expert Review Committee on Polio Eradication and Routine
Immunization (ERC) reviewed the current epidemiology and put forward key
recommendations.
-
Despite the ongoing,
large-scale type 1 outbreak affecting the north of the country, the ERC
noted that 80% of this year's type 1 cases have been reported from six of
the country's 37 states: Bauchi, Jigawa, Kaduna, Kano, Katsina and Zamfara.
-
While progress is evident
in some of these states (notably Jigawa, which has reduced the proportion of
'zero-dose' children from 24% in 2007 to 4% in 2008), the ERC expressed
concern at the ongoing significant operational challenges which continue to
mar the quality of polio campaigns in other states. In Kano, 33% of children
have never been vaccinated, a proportion unchanged since 2007.
-
Among other major
recommendations, the ERC called for enhancing the engagement of state
governors and through them the local government area chairpersons,
particularly in Kano and Zamfara (which together account for 50% of cases
this year). The group noted that in areas where strong state and local
engagement is evident, the operational quality of polio campaigns improved
significantly.
Pakistan
and Afghanistan
-
In 2008, 87 cases have
been reported in Pakistan (63 type 1 and 24 type 3); and 22 cases have been
reported in Afghanistan (17 type 1 and five type 3).
-
In Afghanistan, National
Immunization Days (NIDs) held on 19-21 October focused on increasing access
to all populations, particularly in security-compromised areas of the
Southern Region. Polio is largely restricted to the Southern Region (where
20 of this year's 22 cases occurred).
-
To address the recent
increase in new polio cases in Pakistan, an urgent consultation of experts
convened in Cairo, Egypt, on 10 October. Since July, type 1 polio has spread
into previously polio-free areas of the country, notably Punjab and
Islamabad, causing an outbreak of 25 type 1 cases in Punjab and three type 1
cases in Islamabad. The group also noted a similar increase in type 3 cases
in North West Frontier Province (NWFP), particularly in Peshawar.
-
The urgent consultation
noted that the spread of polio was due to a combination of factors,
including: deteriorating security in known endemic areas (resulting in
increased population movements); an increased susceptibility of populations
in areas free of the disease due to a lower number of SIAs during the last
12 months; suboptimal vaccination coverage in key areas; and, an immunity
gap for type 3 virus in key districts of NWFP due to the suboptimal
vaccination coverage noted above, and compounded by the emphasis given to
the use of mOPV1 in these same districts.
-
The group recommended key
strategic interventions, including: increasing the number of nationwide
campaigns using tOPV to protect children across the country; optimizing
outbreak response in recently re-infected areas using mOPVs as appropriate;
and, increasing the quality of activities in the known transmission zones
(in particular in those areas which are
accessible but continue to be marred by operational challenges, such as
Sindh).
-
In line with these
recommendations, a campaign which had initially been planned as subnational
was expanded to cover the entire country, and was conducted on 13-15
October.
-
Officially launching the
activity, Federal Minister for Health Sherry Rehman emphasized the need for
public commitment, stating: "All of us have to play our role to turn the
dream of a polio-free Pakistan into reality."
-
Despite innovative new
tactics to reach all children (including use of newly-created 'polio control
centres' with key television channels, allowing families not visited by
vaccination teams to call in for corrective action), indications are that
large areas of the Federally Administered Tribal Areas/NWFP were again
inaccessible due to insecurity.
Angola
-
In 2008, 25 cases have
been reported, two type 1 and 23 type 3.
-
Outbreak response
activities are continuing. Following activities with mOPV3 in September,
NIDs were held on 24-26 October (using mOPV1), and nationwide 'accelerated
routine immunization activities' are planned for November and December 2008.
During such activities, a range of vaccines including trivalent OPV will
be offered to communities using a 'fixed vaccination site' approach.
Central
African Republic (CAR)
-
In 2008, two cases have
been reported (both type 1). Three nationwide campaigns have been held, the
latest on 19 September, and two further campaigns are being planned for
24-30 November (combined with measles) and 18-21 December 2008. The risk of
further importations from both Chad (to the north) and the Democratic
Republic of Congo (to the south) remains high.
Chad
-
In 2008, 26 cases have
been reported (one type 1 and 25 type 3).
-
Chad is affected by both
type 1 and type 3 circulation. With suboptimal outbreak response activities
implemented in 2008 (in quality, scope and timeliness of activities), the
risk of further spread of polio within Chad and internationally is high.
-
On 15-16 October, the
Technical Advisory Group on Polio Eradication (TAG) convened in N'Djamena,
to urgently review the situation. The group put forward key recommendations,
including: improved microplans; aggressive interspersed utilisation of
mOPV1, mOPV3 and trivalent OPV; outbreak response within 30 days of
confirmation of any further polio cases; and systematically re-vaccinating
any area where more than 5% of the population has been missed during
previous campaigns.
-
The group also identified
the need for stronger high-level political ownership and engagement,
beginning with the President's office downward. It is strong political
ownership at every level which will ensure that operations are improved
(upwards of 40% of children were regularly missed during campaigns).
-
The TAG recommendations
were presented to the Prime Minister, who expressed concern and provided
assurance of increased government commitment towards polio eradication.
Democratic
Republic of the Congo
-
In 2008, four cases have
been reported (all type 1). With the most recent case in early August,
outbreak response activities are ongoing, with focus on areas along the
Congo River, and border areas of South and North Kivu to prevent further
spread of polio into CAR or Uganda, Burundi and Rwanda.
-
Upcoming immunization
activities may be affected by the increasing insecurity and associated
large-scale population movements, particularly in the two Kivu provinces.
Horn
of Africa
-
In 2008, ten cases have
been reported (one type 3 in West Darfur, Sudan; and nine type 1s from the
southern Sudan/western Ethiopia area).
-
Further outbreak response
campaigns are planned for late October/late November across northern Sudan
and the southern Sudan/western Ethiopia area, using a mix of mOPV1 and
trivalent OPV.
-
The overriding priority
is to stop the type 1 outbreak in southern Sudan/western Ethiopia. The
outbreak here has continued to spread geographically, due to ongoing
vaccination coverage gaps during campaigns. The key challenge remains
accessing all populations (including those living in insecure areas and
remote areas).
Nepal
-
In 2008, five cases have
been reported (all type 3). Nepal remains at risk of importations from
India, and continues to conduct preventive immunization activities.Seven
cases have been reported in the Horn of Africa this year (six cases from the
southern Sudan/western Ethiopia cross-border area, and one case in West Darfur, Sudan).
West Africa
-
In 2008, 18 cases have been reported (all type
1: two in Benin, one in Burkina Faso, two in Ghana and 13 in Niger).
-
West Africa continues to
be at risk of international spread of polio from northern Nigeria.
Confirmation this month of two polio cases in Ghana (previously polio-free
since 2003) further underscores this risk. In 2003-2004, poliovirus
originating from northern Nigeria spread to re-infect eight countries across
west Africa (Benin, Burkina Faso, Cτte d'Ivoire, Ghana, Guinea, Mali, Niger
and Togo).
-
Cross-border outbreak
response campaigns are continuing in late October and November in Benin,
Burkina Faso, Mali and Niger. Outbreak response plans for Ghana have been
finalized; the first round will be held on 13-15 November, and the second on
11-13 December 2008.
________________________________________________________________________
Polio eradication will only succeed if the necessary funds are made
available, and with strong political commitment in polio-affected countries.
More than 10 million children will be paralysed in the next 40 years if the
world fails to capitalize on its >US$5 billion global investment in eradication.
|